Skip to content

Swiftpharma

Active
Private limited companyfounded 2022active for 4 yearsThor Park 8027, 3600 Genk, BelgiumKBO/BCE: BE 0781.598.284
Summary

The computed 12-month bankruptcy probability of Swiftpharma is 2.0% (moderate). The annual accounts of Swiftpharma for financial year 2025 show a net loss of 68% of the equity at the start of that year. The 2025 annual accounts show equity of €834,755 and a net result of -€1.8m. Equity is growing by about 46% per year across the filed financial years. Its solvency ranks better than 24% of 9,594 sector peers (NACE 46, financial year 2025). The company has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow ReportCompare
SwiftpharmaActiveChecked score 53/100
Risk analysis ReportCompare

Group and network

Connections & network

2 current directors
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

We would like to set cookies. That happens only with your consent. What we measure